Quantcast

Daily Archives: January 9, 2007

Divdidendlovers_1

Dividend Lover’s Delight

From Ticker SenseBelow is a list of Russell 3000 companies yielding over 3% whose ex dates are within the next 2 months. http://www.tickersense.typepad.com/ ...
Read Full Story »
Odds_of_5_fed_funds_rate

Take Off The Blinders

From Ticker SenseThe over-riding theme among the major business headlines over the weekend was that the stronger than expected employment report caused investors to sell equities as the Fed is ...
Read Full Story »

Analyzing JP Morgan (JPM)

By Yaser Anwar, CSC of Equity Investment IdeasJPM has posted strong revenues in 2006, driven by solid investment banking fees and excellent trading performance. Management’s outlook for 2007 investment banking ...
Read Full Story »

FIN 48: Slouching Toward Implementation

From AAO WeblogLast June, the FASB released an interpretation of Statement No. 109, which deals with income tax accounting. It was called Interpretation No. 48 (catchy, eh?), “Accounting for Uncertainty ...
Read Full Story »

“Known By The Company You Keep”

From AAO WeblogMaybe the Paulson Committee should be mindful of that old chestnut of moms everywhere. According to this story in the New York Post, there’s good news and bad ...
Read Full Story »

Monday’s Top Biotech and Medical Stocks

From BioHealth InvestorBiotechnologyPOLYMEDIX INC [PYMX.OB] +60.00% SEATTLE GENETICS I [SGEN] +24.01% CYCLACEL PHARMACEUTI [CYCC] +20.93% INNCARDIO INC [ICDO.OB] +19.05% PIPEX PHARMACEUTICAL [PPXP.OB] +12.78% Diagnostic SubstancesIMMUNOMEDICS INC [IMMU] +16.85% ICAGEN, INC. ...
Read Full Story »

Biotech Indices Mixed as AMEX Gains, Nasdaq Slips

From BioHealth Investorby H.S. AyoubBioHealth Investor.comThe major biotech indices were mixed on Monday.The AMEX Biotechnology Index (^BTK) gained more than 3 points, ending trading at $761.54, while the Nasdaq Biotech ...
Read Full Story »

Cramer’s Biotech & Overlooked IPO Picks

On Monday night's MAD MONEY show on CNBC Jim Cramer said there is noreason to wait for the J.P.Morgan Biotech conference, because healready has the stocks to play. This makes ...
Read Full Story »